Particularly, high CD8+ T-cell density is one of the most commonly recognized predictive factors of prognosis as well as response to anti-cancer therapy such as chemotherapy2 and immune checkpoint inhibitor (ICI) therapy3. Here, CD8A is linked to cancer.